Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

By K. Greish. Journal of drug targeting (Print), 2007

602 citations recorded by the source corpus.

Subfields: Biomaterials, Biomedical Engineering, Materials Chemistry

View Paper: https://www.semanticscholar.org/paper/2a0708545d925d76894b4923b1ec559e5a78513d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. S. E. Achy
2. Mohamad T Houri
3. R. Bazak
4. Mariska Bos
5. S. Kamel
6. W. Bult
7. D. Richardson
8. J. Nijsen

In Biomedical Engineering

1. S. E. Achy
2. Mohamad T Houri
3. R. Bazak
4. S. Kamel
5. D. Richardson
6. D. Kalinowski
7. G. Storm
8. T. Refaat

In Materials Chemistry

1. S. E. Achy
2. Mohamad T Houri
3. R. Bazak
4. S. Kamel
5. G. Storm
6. T. Refaat
7. N. Desai

Citations in the corpus

• Challenges in Development of Nanoparticle-Based Therapeutics (2012, background): “A common approach has been to try to get long circulation times with nanomedicines to take advantage of EPR effect or targeting (9).”
• Unraveling the mysteries of serum albumin—more than just a serum protein (2014, background): “1172-1-17 Greish, K. (2007). Enhanced permeability and retention of macromolecular drugs”
• Cancer active targeting by nanoparticles: a comprehensive review of literature (2014, background): “Cancer remains a leading cause of death in humans, and thus, great efforts have been put forward to improve the outcome of cancer management (Greish 2007).”
• Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release (2010, background): “This induces tumor angiogenesis, which allows tumors to grow beyond their diffusion limit (62).”